Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PVLA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
PVLA
Palvella Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PVLA
Palvella Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PVLA
0
None
Shared
0
No disclosed counterparties: PVLA.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
PVLA
Palvella Therapeutics, Inc.
Change
156.51
· pre 156.80
· delayed
Mkt cap
—
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,352.00
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
PVLA
Palvella Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
156.51
pre 156.80
delayed
Price
1,371.32
pre 1,352.00
delayed
—
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
PVLA
156.51
vs
LLY
1,371.32
Pre-market
Nov 6 '26
delayed